Alain Romero
- Pulmonary and Respiratory Medicine top 5%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Wade W. BentonMichael D. McGoonDave P. MillerHillard M. LazarusHaran T. SchlammSaul YanovichJeffrey L. BlumerAdaani Frost
- Topics
- Potassium and Related Disorders (5 papers)Antifungal resistance and susceptibility (4 papers)Heart Failure Treatment and Management (4 papers)
- Cited by
- Infectious DiseasesPulmonary and Respiratory MedicineCardiology and Cardiovascular Medicine
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Alain Romero
17 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Pulmonary and Respiratory Medicine 595
- Infectious Diseases 451
- Epidemiology 425
- Cardiology and Cardiovascular Medicine 402
- Endocrinology, Diabetes and Metabolism 122
Countries citing papers authored by Alain Romero
This map shows the geographic impact of Alain Romero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Romero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Romero more than expected).
Fields of papers citing papers by Alain Romero
This network shows the impact of papers produced by Alain Romero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Romero. The network helps show where Alain Romero may publish in the future.
Co-authorship network of co-authors of Alain Romero
This figure shows the co-authorship network connecting the top 25 collaborators of Alain Romero. A scholar is included among the top collaborators of Alain Romero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Romero. Alain Romero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialbreakdown → | 215 |
| 3 | 3 | |
| 4 | 17 | |
| 5 | 1 | |
| 6 | All-cause costs increase exponentially with increased chronic kidney disease stage. | 107 |
| 7 | 4 | |
| 8 | 27 | |
| 9 | Five-Year Outcomes of Patients Enrolled in the REVEAL Registrybreakdown → | 337 |
| 10 | 9 | |
| 11 | 72 | |
| 12 | 124 | |
| 13 | 29 | |
| 14 | 131 | |
| 15 | 223 | |
| 16 | 3 | |
| 17 | 7 |
About Alain Romero
Alain Romero is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Occupational Therapy, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Potassium and Related Disorders (5 papers), Antifungal resistance and susceptibility (4 papers) and Heart Failure Treatment and Management (4 papers). The work is most often cited by research in Infectious Diseases (451 citations), Pulmonary and Respiratory Medicine (595 citations) and Cardiology and Cardiovascular Medicine (402 citations). Alain Romero has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Wade W. Benton, Michael D. McGoon, Dave P. Miller, Hillard M. Lazarus, Haran T. Schlamm, Saul Yanovich, Jeffrey L. Blumer, Adaani Frost, Raymond L. Benza and C. Gregory Elliott. Their work appears in journals such as The Lancet, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.